Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 4401 - 4408 of 11613 results
SK Hynix Memory Products Infringe Netlist IP, ITC Judge Finds
October 22, 2019| News
Analysis of Attorney General Regulations to CCPA – Part 4: Special Rules Regarding Minors
October 21, 2019| Blog| Viewpoint
HHS Proposes Sweeping Changes to AKS and Stark Law, Part 2: Cybersecurity Technology and Electronic Health Records
October 21, 2019| Blog| Viewpoint
New York City’s Training Requirements Likely Expanded as it Extends NYCHRL Protections to Non-Employees
October 21, 2019| Blog| Viewpoint
Waiving Claims for Public Injunctive Relief in California Arbitration Agreements: The McGill Rule on Appeal
October 18, 2019| Blog| Viewpoint
Analysis of Attorney General Regulations to CCPA – Part 3: Verification Procedures
October 18, 2019| Blog| Viewpoint
Distinguished Leader: Bob Bodian
October 18, 2019| News
Analysis of Attorney General Regulations to CCPA – Part 2: Business Practices for Handling Consumer Requests
October 17, 2019| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.